SMN1 and sporadic amyotrophic lateral sclerosis: A recent study revealed that the expression of miR-663a was significantly increased in the blood of patients with sporadic amyotrophic lateral sclerosis (ALS), a progressive neurodegenerative disorder that affects motor neurons, similar to SMA.47